A7RC peptide modified paclitaxel liposomes dually target breast cancer
作者： Jingyan Cao , Ran Wang , Ning Gao , Minghui Li , Xuyu Tian
DOI: 10.1039/C5BM00161G
关键词: In vivo 、 Angiogenesis 、 Drug carrier 、 Liposome 、 Matrigel 、 Intracellular signal transduction 、 Immunology 、 Peptide modification 、 Peptide 、 Cancer research 、 Medicine
摘要: … paclitaxel liposomes conjugated with the A7RC sequence with the thiol group. Then, high and low NRP-1 expressing breast cancer cell … effects of different paclitaxel formulations in vitro. …
rsc.org
pubmed.cn参考文章(58)
Hai-quan Tao, Qingfeng Meng, Ming-hui Li, Hui Yu, Mei-fang Liu, Dan Du, Shou-li Sun, Hai-cheng Yang, Yan-ming Wang, Wei Ye, Li-zhuang Yang, Da-ling Zhu, Chuan-lu Jiang, Hai-sheng Peng, HP-β-CD-PLGA nanoparticles improve the penetration and bioavailability of puerarin and enhance the therapeutic effects on brain ischemia–reperfusion injury in rats Naunyn-schmiedebergs Archives of Pharmacology. ,vol. 386, pp. 61- 70 ,(2013) , 10.1007/S00210-012-0804-5
Anil Bagri, Marc Tessier-Lavigne, Ryan J. Watts, Neuropilins in Tumor Biology Clinical Cancer Research. ,vol. 15, pp. 1860- 1864 ,(2009) , 10.1158/1078-0432.CCR-08-0563
Haisheng Peng, Dan Du, Jinqiu Zhang, Liposomes modified with p-aminophenyl-α-D-mannopyranoside: a promising delivery system in targeting the brain Therapeutic Delivery. ,vol. 4, pp. 1475- 1477 ,(2013) , 10.4155/TDE.13.113
Angela Catania, Enrique Barrajón-Catalán, Silvia Nicolosi, Federico Cicirata, Vicente Micol, Immunoliposome encapsulation increases cytotoxic activity and selectivity of curcumin and resveratrol against HER2 overexpressing human breast cancer cells. Breast Cancer Research and Treatment. ,vol. 141, pp. 55- 65 ,(2013) , 10.1007/S10549-013-2667-Y
Alex L Kolodkin, Dorothy V Levengood, Erica G Rowe, Yu-Tzu Tai, Roman J Giger, David D Ginty, Neuropilin is a semaphorin III receptor. Cell. ,vol. 90, pp. 753- 762 ,(1997) , 10.1016/S0092-8674(00)80535-8
Ralf-Dieter Hofheinz, Senta Ulrike Gnad-Vogt, Ulrich Beyer, Andreas Hochhaus, Liposomal encapsulated anti-cancer drugs. Anti-Cancer Drugs. ,vol. 16, pp. 691- 707 ,(2005) , 10.1097/01.CAD.0000167902.53039.5A
Diane R. Bielenberg, Michael Klagsbrun, Targeting endothelial and tumor cells with semaphorins Cancer and Metastasis Reviews. ,vol. 26, pp. 421- 431 ,(2007) , 10.1007/S10555-007-9097-4
Anna Starzec, Roger Vassy, Antoine Martin, Marc Lecouvey, Mélanie Di Benedetto, Michel Crépin, Gérard Y. Perret, Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1. Life Sciences. ,vol. 79, pp. 2370- 2381 ,(2006) , 10.1016/J.LFS.2006.08.005
E. A. V. Jones, L. Yuan, C. Breant, R. J. Watts, A. Eichmann, Separating genetic and hemodynamic defects in neuropilin 1 knockout embryos Development. ,vol. 135, pp. 2479- 2488 ,(2008) , 10.1242/DEV.014902
M. Tahara, H. Minami, Y. Hasegawa, K. Tomita, A. Watanabe, K. Nibu, M. Fujii, Y. Onozawa, Y. Kurono, D. Sagae, T. Seriu, M. Tsukuda, Weekly paclitaxel in patients with recurrent or metastatic head and neck cancer Cancer Chemotherapy and Pharmacology. ,vol. 68, pp. 769- 776 ,(2011) , 10.1007/S00280-010-1550-3